Aortic valve disease is often identified too late before clinicans can provide meaningful prevention.

Identifying aortic valve calcium opens the door for potential prevention of progression: a phenotype researchers could build randomized controlled trials around.

In this interview, Richard A. Chazal MD, MACC and Michael J. Blaha, MD, MPH discuss Prevalence of Aortic Valve Calcium and the Long-Term Risk of Incident Severe Aortic Stenosis.

Subscribe on Apple Podcasts | Subscribe to ACCEL